Domov › Alzheimerova choroba › Michigan
Klinické štúdie Alzheimerova choroba v štáte Michigan
15 štúdií pre Alzheimerova choroba hľadá účastníkov v zariadeniach v štáte Michigan.
Mestá v štáte Michigan
Oficiálny text štúdie (anglicky)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
Prebieha náborFáza 4
Vek 50 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
Prebieha náborFáza 1
Vek 50 až 85 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07598370A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
Prebieha náborFáza 2
Vek 55 až 85 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07589595Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
Prebieha náborFáza 3
Vek 50 až 90 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
Prebieha náborFáza 3
Vek 60 až 85 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Prebieha nábor
Vek 70 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- a 5 ďalších
Prebieha nábor
Vek 18 a viac · Ženy · Aktualizované 24. 7. 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 45 až 85 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 60 až 90 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT06584357Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.